Types of Grants

The Scleroderma Foundation wants to foster development of innovative, high-quality research by new and established investigators in fields related to systemic sclerosis (SSc, scleroderma). To accomplish this goal, we offer two distinct research grants: Scleroderma Foundation New Investigator Grant, and the Scleroderma Foundation Established Investigator Grant.

The Foundation has also established a MultiCenter Collaborative Grant for collaborative basic, translational or clinical research projects involving two or more Scleroderma Centers at different institutions. The goal of this new research initiative is to support and enhance collaborations between two or more Scleroderma Centers to advance significant research on scleroderma.

scientist in the labNew Investigator Grant

Purpose: The Scleroderma Foundation seeks applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to systemic sclerosis. This grant supports promising research that is likely to lead to individual research project grants.

Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are not eligible. These new investigator grants may not be used to support thesis or dissertation research or fellowship training. Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences; and must have completed a postdoctoral fellowship by the grant award date. Applicants who have been a principal investigator on grants from the Scleroderma Foundation or other national, private or government agencies other than fellowship grants are not eligible for this award.

Investigators who have questions about eligibility should contact the Scleroderma Foundation at (800) 722-4673 for more information.

Mechanism of Support: Applicants may request up to $50,000 (Up to 8 percent of the direct costs per year of award may be set aside as indirect costs. The indirect costs will be subtracted from the yearly total (up to $50,000) of the award) per year for up to three years (total for three years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek continuing support for research through other grant mechanisms through private or government agencies. Replacement of the principal investigator on this award is not permitted. There will be no routine escalation for future years.

Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements.

Research Objectives: The Scleroderma Foundation New Investigator Grant is designed to facilitate the entry of promising new investigators into areas of research related to scleroderma.

Established Investigator Grant

Purpose: The Scleroderma Foundation seeks applications from promising established investigators both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.

Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are eligible. Applicants must have a doctorate degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences; must have completed a postdoctoral fellowship; and have been principal investigator on grants from the Scleroderma Foundation or other national, private or government agencies in the past.

Investigators who have questions about eligibility should contact the Scleroderma Foundation at (800) 722-4673 for more information.

Mechanism of Support: Applicants may request up to $75,000 (Up to 8 percent of the direct costs per year of award may be set aside as indirect costs. The indirect cost amount will be subtracted from the yearly total [up to $75,000] of the award) per year for up to two years (total for two years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek more substantial continuing support for research through other grant mechanisms through private or government agencies. Replacement of the principal investigator on this award is not permitted. There will be no routine escalation for future years.

Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements.

Research Objectives: The Scleroderma Foundation Established Investigator Grant is designed to facilitate highly innovative or highly relevant and meritorious pilot projects by established investigators in areas of research related to scleroderma that will culminate in more substantial funding from Federal or non-federal granting agencies such as the National Institutes of Health, National Science Foundation and the Department of Defense or Veterans Affairs.

 

MultiCenterGrant